The US Justice Department has subpoenaed Taro Pharmaceutical and two senior company officials requesting information about the drugmaker's pricing practices, as reported CNBC Monday.
Specifically, the subpoenas demanded documents related to "corporate and employee records, generic pharmaceutical products and pricing" and the drugmaker's "communications with competitors and others" concerning the sale of generic products.
"Taro intends to respond to the subpoena and otherwise cooperate with the Department of Justice investigation," the company said.
A 2015 report found that Taro raised the prices of several generic drugs, including a jump in the price of clobetasol from $0.26 per gram to $4.15 per gram.
The news comes after Valeant Pharmaceuticals and Turing Pharmaceuticals were investigated by Congress over price hikes for older products.
Meanwhile, Mylan has recently received scrutiny for price increases for EpiPen, which prompted US presidential candidate Hillary Clinton to propose the creation of a panel to monitor drug pricing.
To read more NewsPoints articles, click here.